Neurocrine Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	713	233	251.1	262.9	340.8
Short-Term Investments	767.4	843.1	780.5	726.4	370.5
Cash & Short-Term Investments	1,480	1,076	1,032	989.3	711.3
Cash Growth	37.57%	4.31%	4.28%	39.08%	-11.20%
Receivables	686.8	479.1	439.3	350	185.5
Inventory	69	57.4	38.3	35.1	30.5
Prepaid Expenses	170.7	-	-	-	-
Other Current Assets	115.8	112.1	97.8	79.1	45.5
Total Current Assets	2,523	1,725	1,607	1,454	972.8
Property, Plant & Equipment	545.2	592	347.3	145.6	155.8
Long-Term Investments	1,184	864.3	849.4	401.5	624.4
Goodwill	-	5.7	5.8	5.4	-
Other Intangible Assets	-	36.5	35.5	37.2	-
Long-Term Deferred Tax Assets	320.3	485.7	362.6	305.9	315.1
Other Long-Term Assets	59.5	9.8	43.8	19.6	4.4
Total Assets	4,632	3,719	3,251	2,369	2,073
Accounts Payable	674.3	110	133.3	67.3	51.5
Accrued Expenses	-	351.6	315.5	271.3	111.6
Current Portion of Long-Term Debt	-	-	170.1	169.4	-
Current Portion of Leases	-	40.6	-	-	-
Current Income Taxes Payable	-	-	-	9	-
Current Unearned Revenue	-	-	-	-	62.7
Other Current Liabilities	69.1	5.5	35.9	20.7	20
Total Current Liabilities	743.4	507.7	654.8	537.7	245.8
Long-Term Debt	-	-	-	-	335.1
Long-Term Leases	415.3	455.1	258.3	93.5	105.3
Other Long-Term Liabilities	219.7	166.2	106.3	29.7	12.3
Total Liabilities	1,378	1,129	1,019	660.9	698.5
Common Stock	0.1	0.1	0.1	0.1	0.1
Additional Paid-In Capital	2,792	2,555	2,382	2,122	2,011
Retained Earnings	447.7	29.2	-157.1	-406.8	-635.8
Comprehensive Income & Other	13.1	5.8	7	-7.9	-1.7
Shareholders' Equity	3,253	2,590	2,232	1,708	1,374
Total Liabilities & Equity	4,632	3,719	3,251	2,369	2,073
Total Debt	415.3	495.7	428.4	262.9	440.4
Net Cash (Debt)	1,065	580.4	603.2	726.4	270.9
Net Cash Growth	83.51%	-3.78%	-16.96%	168.14%	-30.31%
Net Cash Per Share	10.39	5.60	5.97	7.34	2.77
Filing Date Shares Outstanding	100.36	99.7	99.51	96.59	95.24
Total Common Shares Outstanding	100.1	99.4	98.7	96.5	94.9
Working Capital	1,779	1,217	952.2	915.8	727
Book Value Per Share	32.50	26.05	22.61	17.70	14.48
Tangible Book Value	3,253	2,548	2,191	1,665	1,374
Tangible Book Value Per Share	32.50	25.63	22.20	17.26	14.48
Machinery	-	153.2	115.7	87	75.6
Leasehold Improvements	-	35.9	38.1	37.9	34.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.